All changes for the tissue kidney (65)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA288
complement component 1, r subcomponent
Molecular
kidney
Human
C1R
21.0% Increase Gene Expression Level
DAA265
complement component 1, s subcomponent
Molecular
kidney
Human
C1S
24.0% Increase Gene Expression Level
DAA287
creatine kinase, brain
Molecular
kidney
Human
CKB
10.0% Decrease Gene Expression Level
DAA273
cytoplasmic FMR1 interacting protein 2
Molecular
kidney
Human
CYFIP2
11.0% Decrease Gene Expression Level
DAA1062
Creatinine clearance declines
Physiological
kidney
Human
—
—
DAA905
Ability to secrete acid load decreases
Physiological
kidney
Human
—
—
DAA256
defensin, beta 1
Molecular
kidney
Human
DEFB1
8.0% Decrease Gene Expression Level
DAA258
EF-hand domain family, member D1
Molecular
kidney
Human
EFHD1
9.0% Decrease Gene Expression Level
DAA271
epidermal growth factor (beta-urogastrone)
Molecular
kidney
Human
EGF
25.0% Decrease Gene Expression Level
DAA626
Essential (primary) hypertension and hypertensive renal disease
Pathological
heart, kidney
Human
—
SeriesMorbidity
DAA280
FXYD domain containing ion transport regulator 2
Molecular
kidney
Human
FXYD2
5.0% Decrease Gene Expression Level
DAA262
kelch-like 3 (Drosophila)
Molecular
kidney
Human
KLHL3
14.0% Decrease Gene Expression Level
DAA639
Kidney diseases
Pathological
kidney
Human
—
SeriesMorbidity
DAA880
Kidney mass gradually lost
Physiological
kidney
Human
—
—
DAA285
immunoglobulin kappa variable 1-5
Molecular
kidney
Human
IGKV1-5
35.0% Increase Gene Expression Level
DAA620
Hypertensive heart and renal disease
Pathological
heart, kidney
Human
—
SeriesMorbidity
DAA274
immunoglobulin lambda variable 3-25
Molecular
kidney
Human
IGLV3-25
46.0% Increase Gene Expression Level
DAA284
immunoglobulin lambda variable 4-3
Molecular
kidney
Human
IGLV4-3
41.0% Increase Gene Expression Level
DAA261
hypothetical LOC100126583
Molecular
kidney
Human
—
43.0% Increase Gene Expression Level
DAA260
hypothetical protein LOC284214
Molecular
kidney
Human
—
53.0% Increase Gene Expression Level
DAA259
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides
Molecular
kidney
Human
IGJ
60.0% Increase Gene Expression Level
DAA894
Interstitial fibrosis in medulla
Physiological
kidney
Human
—
—
DAA257
kininogen 1
Molecular
kidney
Human
KNG1
17.0% Decrease Gene Expression Level
DAA891
Nephrons appear to fail as units
Physiological
nephron
Human
—
—
DAA895
Basement membranes of glomeruli and tubules thicken
Physiological
renal tubule, glomerulus
Human
—
—
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA288 | complement component 1, r subcomponent | Molecular | kidney | Human | C1R | 21.0% Increase Gene Expression Level | |
DAA265 | complement component 1, s subcomponent | Molecular | kidney | Human | C1S | 24.0% Increase Gene Expression Level | |
DAA287 | creatine kinase, brain | Molecular | kidney | Human | CKB | 10.0% Decrease Gene Expression Level | |
DAA273 | cytoplasmic FMR1 interacting protein 2 | Molecular | kidney | Human | CYFIP2 | 11.0% Decrease Gene Expression Level | |
DAA1062 | Creatinine clearance declines | Physiological | kidney | Human | — | — | |
DAA905 | Ability to secrete acid load decreases | Physiological | kidney | Human | — | — | |
DAA256 | defensin, beta 1 | Molecular | kidney | Human | DEFB1 | 8.0% Decrease Gene Expression Level | |
DAA258 | EF-hand domain family, member D1 | Molecular | kidney | Human | EFHD1 | 9.0% Decrease Gene Expression Level | |
DAA271 | epidermal growth factor (beta-urogastrone) | Molecular | kidney | Human | EGF | 25.0% Decrease Gene Expression Level | |
DAA626 | Essential (primary) hypertension and hypertensive renal disease | Pathological | heart, kidney | Human | — | SeriesMorbidity | |
DAA280 | FXYD domain containing ion transport regulator 2 | Molecular | kidney | Human | FXYD2 | 5.0% Decrease Gene Expression Level | |
DAA262 | kelch-like 3 (Drosophila) | Molecular | kidney | Human | KLHL3 | 14.0% Decrease Gene Expression Level | |
DAA639 | Kidney diseases | Pathological | kidney | Human | — | SeriesMorbidity | |
DAA880 | Kidney mass gradually lost | Physiological | kidney | Human | — | — | |
DAA285 | immunoglobulin kappa variable 1-5 | Molecular | kidney | Human | IGKV1-5 | 35.0% Increase Gene Expression Level | |
DAA620 | Hypertensive heart and renal disease | Pathological | heart, kidney | Human | — | SeriesMorbidity | |
DAA274 | immunoglobulin lambda variable 3-25 | Molecular | kidney | Human | IGLV3-25 | 46.0% Increase Gene Expression Level | |
DAA284 | immunoglobulin lambda variable 4-3 | Molecular | kidney | Human | IGLV4-3 | 41.0% Increase Gene Expression Level | |
DAA261 | hypothetical LOC100126583 | Molecular | kidney | Human | — | 43.0% Increase Gene Expression Level | |
DAA260 | hypothetical protein LOC284214 | Molecular | kidney | Human | — | 53.0% Increase Gene Expression Level | |
DAA259 | immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides | Molecular | kidney | Human | IGJ | 60.0% Increase Gene Expression Level | |
DAA894 | Interstitial fibrosis in medulla | Physiological | kidney | Human | — | — | |
DAA257 | kininogen 1 | Molecular | kidney | Human | KNG1 | 17.0% Decrease Gene Expression Level | |
DAA891 | Nephrons appear to fail as units | Physiological | nephron | Human | — | — | |
DAA895 | Basement membranes of glomeruli and tubules thicken | Physiological | renal tubule, glomerulus | Human | — | — |